Key Insights

Highlights

Success Rate

94% trial completion (above average)

Published Results

198 trials with published results (24%)

Research Maturity

670 completed trials (80% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

5.1%

43 terminated out of 838 trials

Success Rate

94.0%

+7.5% vs benchmark

Late-Stage Pipeline

37%

307 trials in Phase 3/4

Results Transparency

30%

198 of 670 completed with results

Key Signals

198 with results94% success43 terminated

Data Visualizations

Phase Distribution

717Total
Not Applicable (223)
Early P 1 (6)
P 1 (73)
P 2 (108)
P 3 (194)
P 4 (113)

Trial Status

Completed670
Unknown58
Terminated43
Recruiting21
Not Yet Recruiting16
Active Not Recruiting12

Trial Success Rate

94.0%

Benchmark: 86.5%

Based on 670 completed trials

Clinical Trials (838)

Showing 20 of 20 trials
NCT07477704Phase 2RecruitingPrimary

A Study to See How Safe and Effective Alirocumab is When Given Weekly to Adult Participants Who Have Hypercholesterolemia

NCT06556745CompletedPrimary

Pharmacokinetics of Butyrate Tablet BKR-017

NCT00353782RecruitingPrimary

Causes and Natural History of Dyslipidemias

NCT07634484Phase 4Not Yet RecruitingPrimary

A Post-Marketing Clinical Trial of Pemafibrate in Patients with Hypercholesterolemia and Inadequate Response to Statins

NCT07581808Phase 4RecruitingPrimary

Dual PCSK9 Inhibition With Inclisiran and Alirocumab in Secondary Prevention

NCT00221754Phase 2Completed

Pravastatin and Protease Inhibitors in HIV-infected Patients

NCT06065098Not ApplicableActive Not Recruiting

Church-based Health Intervention to Eliminate Racial Inequalities in Cardiovascular Health

NCT00001154Completed

Lipoprotein Metabolism in Normal Volunteers and Patients With High Levels of Lipoproteins

NCT06423365Not ApplicableCompleted

A Tool to Help Patients With Muscle Symptoms After Taking a Statin Medication.

NCT07524101Not ApplicableNot Yet Recruiting

Moderate-Intensity Statin Plus Ezetimibe in CKD and ASCVD

NCT06960655Not ApplicableEnrolling By InvitationPrimary

Improving Lipid Optimization Quality and Treatment Options in ASCVD

NCT07406191Not ApplicableActive Not Recruiting

WB-EMS Effects on Cardiometabolic Risk Factors

NCT07026266Not ApplicableCompletedPrimary

Study on the Effect of the Intake of a Calcium-bicarbonate Water on Cholesterol Levels

NCT07564726Phase 3Completed

Efficacy and Safety of Ezetimibe/Rosuvastatin and Amlodipine Patients With High Blood Pressure and High Cholesterol

NCT07447206Phase 2Not Yet Recruiting

Vascular Intervention Strategies Trial for Alzheimer's

NCT06451770Phase 1RecruitingPrimary

Phase 1b Study of VERVE-201 in Patients With Refractory Hyperlipidemia

NCT07514663Not ApplicableRecruitingPrimary

Assessing the Effects of Corn and Avocado Oils on the Cardiometabolic Risk Factor Profile

NCT05362903CompletedPrimary

A Non-interventional Implementation Study to Evaluate Treatment With Inclisiran (Leqvio®) and Other Lipid Lowering Treatments in a Real-world Setting

NCT05192941Phase 4CompletedPrimary

Study of Efficacy, Safety, Tolerability and Quality of Life of Inclisiran (KJX839) vs Placebo, on Top of Ongoing Individually Optimized Lipid-lowering Therapy, in Participants With Hypercholesterolemia

NCT07175766Not ApplicableCompleted

Dachundou No Sugar Added Soymilk for Lipid Modulation

Scroll to load more

Research Network

Activity Timeline